Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort …
…, C Auphimai, D Srimuan, T Thatsanatorn… - Human vaccines & …, 2022 - Taylor & Francis
In light of intermittent supply shortages of individual vaccines and evidence of rare but serious
adverse events after vaccination, heterologous regimens for COVID-19 vaccines have …
adverse events after vaccination, heterologous regimens for COVID-19 vaccines have …
Neutralizing activities against the Omicron variant after a heterologous booster in healthy adults receiving two doses of CoronaVac vaccination
…, D Srimuan, T Thatsanatorn… - The Journal of …, 2022 - academic.oup.com
Background The use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine (CoronaVac) against SARS-CoV-2 is implemented worldwide. However, …
vaccine (CoronaVac) against SARS-CoV-2 is implemented worldwide. However, …
Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated …
…, T Thongmee, R Yorsaeng, D Srimuan, T Thatsanatorn… - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has become a severe healthcare
problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 …
problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 …
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
…, L Wongsrisang, D Srimuan, T Thatsanatorn… - Vaccine, 2022 - Elsevier
In June 2021, Thailand was hit by the delta variant of SARS-CoV-2 resulting in the biggest
wave of COVID-19. Due to the widespread delta variant, more than 600 healthcare workers …
wave of COVID-19. Due to the widespread delta variant, more than 600 healthcare workers …
Effects of boosted mRNA and adenoviral‐vectored vaccines on immune responses to omicron BA. 1 and BA. 2 following the heterologous CoronaVac/AZD1222 …
…, D Srimuan, T Thatsanatorn… - Journal of Medical …, 2022 - Wiley Online Library
The coronavirus 2019 omicron variant has surged rapidly and raises concerns about immune
evasion even in individuals with complete vaccination, because it harbors mutations. Here …
evasion even in individuals with complete vaccination, because it harbors mutations. Here …
Immunogenicity following two doses of the BBIBP-CorV vaccine and a third booster dose with a viral vector and mRNA COVID-19 vaccines against delta and omicron …
…, L Wongsrisang, D Srimuan, T Thatsanatorn… - Vaccines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) booster vaccination is being comprehensively
evaluated globally due to waning immunity and the emergence of new severe acute respiratory …
evaluated globally due to waning immunity and the emergence of new severe acute respiratory …
COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity …
…, L Wongsrisang, D Srimuan, T Thatsanatorn… - Vaccines, 2022 - mdpi.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
and the waning of immunity in vaccinated individuals is resulting in increased numbers of …
and the waning of immunity in vaccinated individuals is resulting in increased numbers of …
[HTML][HTML] Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens
…, W Withaksabut, D Srimuan, T Thatsanatorn… - International Journal of …, 2023 - Elsevier
Objectives To report the safety and immunogenicity profile of a protein subunit vaccine (Covovax
TM ) given as a third (booster) dose to individuals primed with different primary vaccine …
TM ) given as a third (booster) dose to individuals primed with different primary vaccine …
Strong correlations between the binding antibodies against wild-type and neutralizing antibodies against Omicron BA. 1 and BA. 2 variants of SARS-CoV-2 in …
…, P Nilyanimit, D Srimuan, T Thatsanatorn… - Diagnostics, 2022 - mdpi.com
This study examined the neutralizing activity and receptor-binding domain (RBD) antibody
levels against wild-type and omicron BA.1 and BA.2 variants in individuals who received …
levels against wild-type and omicron BA.1 and BA.2 variants in individuals who received …
[HTML][HTML] Persistence of immunity against Omicron BA. 1 and BA. 2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after …
…, P Pakchotanon, D Srimuan, T Thatsanatorn… - International Journal of …, 2022 - Elsevier
Objectives The SARS-CoV-2 Omicron variant presents numerous mutations potentially able
to evade neutralizing antibodies (NAbs) elicited by COVID-19 vaccines. Therefore, this study …
to evade neutralizing antibodies (NAbs) elicited by COVID-19 vaccines. Therefore, this study …
